Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
After finishing at $3.77 in the prior trading day, Quince Therapeutics Inc (NASDAQ: QNCX) closed at $3.7, down -1.86%. In other words, the price has decreased by -$1.86 from its previous closing price. On the day, 1.11 million shares were traded. QNCX stock price reached its highest trading level at $4.0 during the session, while it also had its lowest trading level at $3.7.
Ratios:
Our goal is to gain a better understanding of QNCX by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.12 and its Current Ratio is at 1.12. In the meantime, Its Debt-to-Equity ratio is 16.97 whereas as Long-Term Debt/Eq ratio is at 0.34.
Upgrades & Downgrades
In the most recent recommendation for this company, Citizens JMP on August 05, 2025, initiated with a Mkt Outperform rating and assigned the stock a target price of $9. On March 24, 2025, Oppenheimer started tracking the stock assigning a Outperform rating and target price of $10.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, QNCX now has a Market Capitalization of 206021504 and an Enterprise Value of 197726512.
Stock Price History:
The Beta on a monthly basis for QNCX is 1.14, which has changed by 1.0378377 over the last 52 weeks, in comparison to a change of 0.16081822 over the same period for the S&P500. Over the past 52 weeks, QNCX has reached a high of $4.55, while it has fallen to a 52-week low of $0.72. The 50-Day Moving Average of the stock is 55.67%, while the 200-Day Moving Average is calculated to be 123.32%.
Shares Statistics:
The stock has traded on average 632.26K shares per day over the past 3-months and 1177850 shares per day over the last 10 days, according to various share statistics. A total of 54.49M shares are outstanding, with a floating share count of 48.30M. Insiders hold about 13.25% of the company’s shares, while institutions hold 20.78% stake in the company. Shares short for QNCX as of 1764288000 were 1551992 with a Short Ratio of 2.45, compared to 1761868800 on 1311476. Therefore, it implies a Short% of Shares Outstanding of 1551992 and a Short% of Float of 3.11.
Earnings Estimates
The dynamic stock of Quince Therapeutics Inc (QNCX) is currently attracting attention from 3.0 analysts actively involved in rating its market status.The consensus estimate for the next quarter is -$0.2, with high estimates of -$0.15 and low estimates of -$0.23.
Analysts are recommending an EPS of between -$1.03 and -$1.15 for the fiscal current year, implying an average EPS of -$1.08. EPS for the following year is -$0.72, with 4.0 analysts recommending between -$0.11 and -$1.24.
